Fielder Capital Group LLC Purchases 235 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fielder Capital Group LLC lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,488 shares of the company’s stock after acquiring an additional 235 shares during the period. Fielder Capital Group LLC’s holdings in Doximity were worth $293,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Shaker Investments LLC OH bought a new stake in shares of Doximity in the 4th quarter worth $559,000. Fountainhead AM LLC purchased a new stake in shares of Doximity during the third quarter valued at $710,000. Penserra Capital Management LLC bought a new stake in Doximity in the 3rd quarter worth about $2,384,000. Newbridge Financial Services Group Inc. purchased a new position in Doximity in the 4th quarter worth about $362,000. Finally, Principal Financial Group Inc. lifted its stake in Doximity by 1.5% during the 4th quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock valued at $15,695,000 after acquiring an additional 4,282 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Stock Performance

Shares of Doximity stock opened at $69.54 on Friday. The company has a fifty day moving average of $61.66 and a 200 day moving average of $50.26. The company has a market capitalization of $12.98 billion, a P/E ratio of 69.54, a P/E/G ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21.

Analysts Set New Price Targets

A number of brokerages have recently commented on DOCS. Truist Financial lifted their price target on shares of Doximity from $35.00 to $49.00 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Canaccord Genuity Group lifted their target price on shares of Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Mizuho increased their price target on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Finally, Bank of America increased their target price on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 37.40% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.